The Stability and Complexity of Antibody Responses to the Major Surface Antigen of Plasmodium falciparum Are Associated with Age in a Malaria Endemic Area*

Individuals that are exposed to malaria eventually develop immunity to the disease with one possible mechanism being the gradual acquisition of antibodies to the range of parasite variant surface antigens in their local area. Major antibody targets include the large and highly polymorphic Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) family of proteins. Here, we use a protein microarray containing 123 recombinant PfEMP1-DBLα domains (VAR) from Papua New Guinea to seroprofile 38 nonimmune children (<4 years) and 29 hyperimmune adults (≥15 years) from the same local area. The overall magnitude, prevalence and breadth of antibody response to VAR was limited at <2 years and 2–2.9 years, peaked at 3–4 years and decreased for adults compared with the oldest children. An increasing proportion of individuals recognized large numbers of VAR proteins (>20) with age, consistent with the breadth of response stabilizing with age. In addition, the antibody response was limited in uninfected children compared with infected children but was similar in adults irrespective of infection status. Analysis of the variant-specific response confirmed that the antibody signature expands with age and infection. This also revealed that the antibody signatures of the youngest children overlapped substantially, suggesting that they are exposed to the same subset of PfEMP1 variants. VAR proteins were either seroprevalent from early in life, (<3 years), from later in childhood (≥3 years) or rarely recognized. Group 2 VAR proteins (Cys2/MFK-REY+) were serodominant in infants (<1-year-old) and all other sequence subgroups became more seroprevalent with age. The results confirm that the anti-PfEMP1-DBLα antibody responses increase in magnitude and prevalence with age and further demonstrate that they increase in stability and complexity. The protein microarray approach provides a unique platform to rapidly profile variant-specific antibodies to malaria and suggests novel insights into the acquisition of immunity to malaria.

[1]  Matthew A. Kayala,et al.  Sterile Protective Immunity to Malaria is Associated with a Panel of Novel P. falciparum Antigens* , 2011, Molecular & Cellular Proteomics.

[2]  A. van Dorsselaer,et al.  Unusual N-glycan Structures Required for Trafficking Toxoplasma gondii GAP50 to the Inner Membrane Complex Regulate Host Cell Entry Through Parasite Motility* , 2011, Molecular & Cellular Proteomics.

[3]  Kevin Marsh,et al.  A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa , 2011, PloS one.

[4]  T. Theander,et al.  Hierarchical, Domain Type-Specific Acquisition of Antibodies to Plasmodium falciparum Erythrocyte Membrane Protein 1 in Tanzanian Children , 2010, Infection and Immunity.

[5]  Pierre Baldi,et al.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray , 2010, Proceedings of the National Academy of Sciences.

[6]  M. Nunes,et al.  Immune Selection and Within-Host Competition Can Structure the Repertoire of Variant Surface Antigens in Plasmodium falciparum - A Mathematical Model , 2010, PloS one.

[7]  Jack S. Richards,et al.  The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis , 2010, PLoS medicine.

[8]  Thomas M. Keane,et al.  Plasmodium falciparum var gene expression is modified by host immunity , 2009, Proceedings of the National Academy of Sciences.

[9]  T. Theander,et al.  Sequential, Ordered Acquisition of Antibodies to Plasmodium falciparum Erythrocyte Membrane Protein 1 Domains1 , 2009, The Journal of Immunology.

[10]  A. Craig,et al.  Sequence variation of PfEMP1-DBLα in association with rosette formation in Plasmodium falciparum isolates causing severe and uncomplicated malaria , 2009, Malaria Journal.

[11]  M. Ott,et al.  Analysis of Plasmodium falciparum var genes expressed in children from Papua New Guinea. , 2009, The Journal of infectious diseases.

[12]  P. Gilson,et al.  Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness , 2009, Infection and Immunity.

[13]  Arlo Z. Randall,et al.  Profiling humoral immune responses to P. falciparum infection with protein microarrays , 2008, Proteomics.

[14]  C. Newbold,et al.  Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1 , 2008, Malaria Journal.

[15]  T. Theander,et al.  A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma , 2008, Malaria Journal.

[16]  R. Ripley,et al.  Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea , 2008, Malaria Journal.

[17]  P. Earl,et al.  Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of Dryvax , 2007, Journal of Virology.

[18]  M. Wahlgren,et al.  PfEMP1-DBL1α amino acid motifs in severe disease states of Plasmodium falciparum malaria , 2007, Proceedings of the National Academy of Sciences.

[19]  Caroline O. Buckee,et al.  An approach to classifying sequence tags sampled from Plasmodium falciparum var genes , 2007, Molecular and biochemical parasitology.

[20]  G. McVean,et al.  Population Genomics of the Immune Evasion (var) Genes of Plasmodium falciparum , 2007, PLoS pathogens.

[21]  T. Theander,et al.  3D7-Derived Plasmodium falciparum Erythrocyte Membrane Protein 1 Is a Frequent Target of Naturally Acquired Antibodies Recognizing Protein Domains in a Particular Pattern Independent of Malaria Transmission Intensity1 , 2007, The Journal of Immunology.

[22]  M. Wahlgren,et al.  PfEMP1-DBL1alpha amino acid motifs in severe disease states of Plasmodium falciparum malaria. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Richard J. Challis,et al.  Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia , 2006, Molecular and biochemical parasitology.

[24]  João Eduardo Ferreira,et al.  Extense variant gene family repertoire overlap in Western Amazon Plasmodium falciparum isolates. , 2006, Molecular and biochemical parasitology.

[25]  Pierre Baldi,et al.  Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques , 2006, Bioinform..

[26]  T. Theander,et al.  Differential Expression of var Gene Groups Is Associated with Morbidity Caused by Plasmodium falciparum Infection in Tanzanian Children , 2006, Infection and Immunity.

[27]  K. Piper,et al.  Haptoglobin levels are associated with haptoglobin genotype and alpha+ -Thalassemia in a malaria-endemic area. , 2006, The American journal of tropical medicine and hygiene.

[28]  Mirjam Kaestli,et al.  Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. , 2006, The Journal of infectious diseases.

[29]  K. Marsh,et al.  Immune effector mechanisms in malaria , 2006, Parasite immunology.

[30]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[31]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[32]  Neil Hall,et al.  Plasmodium falciparum Variant Surface Antigen Expression Patterns during Malaria , 2005, PLoS pathogens.

[33]  M. Wahlgren,et al.  SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes , 2005, The Journal of experimental medicine.

[34]  T. Theander,et al.  Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans , 2005, Malaria Journal.

[35]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[36]  Pierre Baldi,et al.  Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Mario Recker,et al.  Transient cross-reactive immune responses can orchestrate antigenic variation in malaria , 2004, Nature.

[38]  S. Sharp,et al.  Plasmodium falciparum Associated with Severe Childhood Malaria Preferentially Expresses PfEMP1 Encoded by Group A var Genes , 2004, The Journal of experimental medicine.

[39]  Kathryn S. Lilley,et al.  DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results , 2004, Bioinform..

[40]  P. Kremsner,et al.  Commonly recognised Plasmodium falciparum parasites cause cerebral malaria , 2003, Parasitology Research.

[41]  Pierre Baldi,et al.  DNA Microarrays and Gene Expression - From Experiments to Data Analysis and Modeling , 2002 .

[42]  Thor G. Theander,et al.  Plasmodium falciparum Variant Surface Antigen Expression Varies Between Isolates Causing Severe and Nonsevere Malaria and Is Modified by Acquired Immunity1 , 2002, The Journal of Immunology.

[43]  M. Gatton,et al.  Genetic diversity of the DBLalpha region in Plasmodium falciparum var genes among Asia-Pacific isolates. , 2002, Molecular and biochemical parasitology.

[44]  K. Kirchgatter,et al.  Association of Severe Noncerebral Plasmodium falciparum Malaria in Brazil With Expressed PfEMP1 DBL1α Sequences Lacking Cysteine Residues , 2002, Molecular Medicine.

[45]  A. Poustka,et al.  Transcription profiling of renal cell carcinoma. , 2002, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[46]  P. Kremsner,et al.  High Prevalence of Human Antibodies to Recombinant Duffy Binding-Like α Domains of the Plasmodium falciparum-Infected Erythrocyte Membrane Protein 1 in Semi-Immune Adults Compared to That in Nonimmune Children , 2001, Infection and Immunity.

[47]  A D Long,et al.  Improved Statistical Inference from DNA Microarray Data Using Analysis of Variance and A Bayesian Statistical Framework , 2001, The Journal of Biological Chemistry.

[48]  Pierre Baldi,et al.  A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes , 2001, Bioinform..

[49]  S. Kyes,et al.  Var gene diversity in Plasmodium falciparum is generated by frequent recombination events. , 2000, Molecular and biochemical parasitology.

[50]  C. Newbold,et al.  Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. , 2000, The Journal of infectious diseases.

[51]  R. Hayward,et al.  Malaria Transmission and Naturally Acquired Immunity to PfEMP-1 , 1999, Infection and Immunity.

[52]  S. Kyes,et al.  Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Hayward,et al.  Virulence and transmission success of the malarial parasite Plasmodium falciparum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Christl A. Donnelly,et al.  Immunity to non-cerebral severe malaria is acquired after one or two infections , 1999, Nature Medicine.

[55]  Kevin Marsh,et al.  Antibody Recognition of Plasmodium falciparum Erythrocyte Surface Antigens in Kenya: Evidence for Rare and Prevalent Variants , 1999, Infection and Immunity.

[56]  Q. Cheng,et al.  stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. , 1998, Molecular and biochemical parasitology.

[57]  Mats Wahlgren,et al.  Developmental selection of var gene expression in Plasmodium falciparum , 1998, Nature.

[58]  Kevin Marsh,et al.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria , 1998, Nature Medicine.

[59]  A. Craig,et al.  Receptor-specific adhesion and clinical disease in Plasmodium falciparum. , 1997, The American journal of tropical medicine and hygiene.

[60]  A. Craig,et al.  Genomic representation of var gene sequences in Plasmodium falciparum field isolates from different geographic regions. , 1997, Molecular and biochemical parasitology.

[61]  Yang,et al.  P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1 , 1997, Nature.

[62]  M. Alpers,et al.  The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. , 1995, Annals of tropical medicine and parasitology.

[63]  M. Alpers,et al.  The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. , 1995, Annals of tropical medicine and parasitology.

[64]  Theodore F. Taraschi,et al.  Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes , 1995, Cell.

[65]  Joseph D. Smith,et al.  Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes , 1995, Cell.

[66]  X. Su,et al.  The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes , 1995, Cell.

[67]  M. Alpers,et al.  Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[68]  A. Sabchareon,et al.  Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. , 1991, The American journal of tropical medicine and hygiene.

[69]  T. Smith,et al.  Diversity of antigens expressed on the surface of erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea. , 1989, The American journal of tropical medicine and hygiene.

[70]  T. Burkot,et al.  Human malaria transmission studies in the Anopheles punctulatus complex in Papua New Guinea: sporozoite rates, inoculation rates, and sporozoite densities. , 1988, The American journal of tropical medicine and hygiene.

[71]  K. Marsh,et al.  Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. , 1986, Science.

[72]  M. Alpers,et al.  The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. , 1986, The American journal of tropical medicine and hygiene.

[73]  J. Barnwell,et al.  Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes , 1984, The Journal of experimental medicine.

[74]  J. Barnwell,et al.  Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[75]  I. N. Brown,et al.  Immunity to Malaria: Antigenic Variation in Chronic Infections of Plasmodium knowlesi , 1965, Nature.

[76]  I. McGregor.  THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY. , 1964, The American journal of tropical medicine and hygiene.

[77]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[78]  W H TALIAFERRO,et al.  Acquired immunity in malaria. , 1948, Abstracts. International Congress on Tropical Medicine and Malaria.